HDEP-28

Source: Wikipedia, the free encyclopedia.
HDEP-28
Legal status
Legal status
Identifiers
  • Ethyl (naphthalen-2-yl)(piperidin-2-yl)acetate
JSmol)
  • CCOC(=O)C(C1CCCCN1)c2ccc3ccccc3c2
  • InChI=1S/C19H23NO2/c1-2-22-19(21)18(17-9-5-6-12-20-17)16-11-10-14-7-3-4-8-15(14)13-16/h3-4,7-8,10-11,13,17-18,20H,2,5-6,9,12H2,1H3
  • Key:OTQVTBPHZRARTL-UHFFFAOYSA-N

HDEP-28 or ethylnaphthidate is a piperidine based stimulant drug, closely related to ethylphenidate, but with the benzene ring replaced by naphthalene. It is even more closely related to HDMP-28, which acts as a potent serotonin–norepinephrine–dopamine reuptake inhibitor with several times the potency of methylphenidate and a short duration of action.[1] It has been sold as a designer drug since around 2015.[2]

Legality

HDEP-28 was banned in the UK as a

Temporary Class Drug from June 2015 following its unapproved sale as a designer drug, alongside 4-Methylmethylphenidate.[3][4][5]

See also

References

  1. S2CID 5654856
    .
  2. PMID 28823611
  3. ^ Methylphenidate-based NPS: A review of the evidence of use and harm. Advisory Council on the Misuse of Drugs, 31 March 2015
  4. ^ "Letter to Mike Penning on methylphenidate-based novel psychoactive substances". Advisory Council on the Misuse of Drugs. 25 June 2015. Retrieved 25 June 2015.
  5. ^ "Ministerial response to the Advisory Council on the Misuse of Drugs about 2 new methylphenidate-based substances". Home Office. 25 June 2015. Retrieved 25 June 2015.
Retrieved from "https://en.wikipedia.org/w/index.php?title=HDEP-28&oldid=1187980335"